官方服务：
资源简介：
Codebook for the database of the research study called: " Post-trial follow-up after a randomized clinical trial of COVID-19 convalescent plasma"
应用场景：
创建时间：
2022-07-21
相关数据集
Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)
ABSTRACT Introduction: Pro-inflammatory markers play a significant role in the disease severity of patients with COVID-19. Thus, anti-inflammatory therapies are attractive agents for potentially com
NIAID Data Ecosystem50
Plasma virome dynamics in chronic hepatitis B virus infected patients
In this study we have sequenced the virome in longitudinal plasma samples of chronic hepatitis B virus (HBV) infected patients. Patients were diagnosed in different stages of chronic HBV infection. Th
NIAID Data Ecosystem30
Additional file 1 of Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes
Additional file 1: Table S1. List of the 297 plasma proteins assayed.
Figshare2022-03-09 更新30
Data_Sheet_1_Building and implementing a contactless clinical trial protocol for patients with COVID-19: A Korean perspective.pdf
IntroductionTo effectively manage patients with coronavirus disease 2019 (COVID-19) while minimizing contact between medical staff, clinical trial protocol that facilitates contactless patient managem
NIAID Data Ecosystem40
Table_7_Autologous Platelet- and Extracellular Vesicle-Rich Plasma Is an Effective Treatment Modality for Chronic Postoperative Temporal Bone Cavity Inflammation: Randomized Controlled Clinical Trial.DOCX
PurposeTo determine the efficacy of autologous platelet- and extracellular vesicle-rich plasma (PVRP) to treat chronic postoperative temporal bone cavity inflammation (CPTBCI) after exhausting surgica
NIAID Data Ecosystem30
